Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia.
about
Where does a Staphylococcus aureus vaccine stand?Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapiesHuman cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting.Plasma HSPA12B is a potential predictor for poor outcome in severe sepsisHost cytokine responses distinguish invasive from airway isolates of the Streptococcus milleri/anginosis group.The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammationHost gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model.Significance of mannose-binding lectin deficiency and nucleotide-binding oligomerization domain 2 polymorphisms in Staphylococcus aureus bloodstream infections: a case-control study.Immune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality.High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment.Interleukin-10 and soil-transmitted helminth infections in Honduran children.Uncoupling of pro- and anti-inflammatory properties of Staphylococcus aureus.Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection.Immunomodulation and Disease Tolerance to Staphylococcus aureusStaphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus BacteremiaStaphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design.Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy.Staphylococcus aureus bacteremia: targeting the source.Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia.Potential effects of omega-3 fatty acids on anemia and inflammatory markers in maintenance hemodialysis patients.Ratio of T-Helper Type 1 (Th1) to Th17 Cytokines in Whole Blood Is Associated With Human β-Defensin 3 Expression in Skin and Persistent Staphylococcus aureus Nasal Carriage.Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia.HLA-DR polymorphisms influence in vivo responses to staphylococcal toxic shock syndrome toxin-1 in a transgenic mouse model.Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality.Daptomycin selects for genetic and phenotypic adaptations leading to antibiotic tolerance in MRSA.
P2860
Q26828726-E8B9A212-0301-454C-9189-FE6C9A418E47Q26852697-391B4CAE-8939-4D35-8E8A-A5D6BA772F25Q33703659-CA208FE1-084E-4847-871D-7480C8D2C0A4Q33825845-4FDB8C3B-14A3-4797-B8B0-21C7F79FDD32Q34246158-4E02D7F5-2010-408C-8727-E815C5E46A09Q34374054-50ABE7EF-B184-41AE-97F5-451EF0141C86Q34658467-25906D30-984C-49F6-948B-57B4040E7001Q35006249-2E67A77A-64D1-413C-82F2-2BE021744EBDQ35088590-FB021A2A-CAC3-4D58-A42B-0D0113B0FE43Q35092654-83A0AE15-6701-4366-A1B6-34BD23028723Q35141085-61069900-5085-40D2-9685-36C65817232BQ35187585-E4AC4672-55BB-4690-B937-8A995806000BQ35833250-F2AE3C0C-8F0A-44C7-A4B3-A4FABF72085BQ36409380-D401AFBD-D66B-4393-B28A-EB2A670C7B24Q37332203-8B601AF1-4981-463E-8818-356C223C2754Q37358638-1B206F4D-6021-4194-A4D1-6D9487F565B9Q38177271-07C3FDBD-E0FC-4AFC-91AC-B552B84820D5Q38232494-71A56633-0B03-4F26-8104-75991DB563FEQ38258108-B2CC42D1-8770-4C34-81D9-45A66E507EB4Q38958136-3956CEE7-EC64-4CFA-9FF0-D0FD89EF6629Q39278083-582B4E66-4850-4EDA-A06A-5C8BE79DA14AQ39312275-2AC15BDE-8AA6-4BDF-AC4C-2E6CE301826AQ40378887-2E8CB983-BE78-4EF1-87D4-A5FA9EB37362Q40445297-EDB6B3F5-4470-49F9-BA35-1A39D484FB02Q52563129-D2E52990-1A49-402D-A894-E678B7DC1BB1Q54223291-7CB3FAAE-0792-45EE-8483-7E0351885C08
P2860
Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Elevated serum interleukin-10 ...... phylococcus aureus bacteremia.
@en
Elevated serum interleukin-10 ...... phylococcus aureus bacteremia.
@nl
type
label
Elevated serum interleukin-10 ...... phylococcus aureus bacteremia.
@en
Elevated serum interleukin-10 ...... phylococcus aureus bacteremia.
@nl
prefLabel
Elevated serum interleukin-10 ...... phylococcus aureus bacteremia.
@en
Elevated serum interleukin-10 ...... phylococcus aureus bacteremia.
@nl
P2093
P2860
P356
P1476
Elevated serum interleukin-10 ...... aphylococcus aureus bacteremia
@en
P2093
George Sakoulas
Jens C Eickhoff
Madhulatha Pantrangi
Sanjay K Shukla
Sara E Cosgrove
Suzan Rooijakkers
Warren E Rose
P2860
P304
P356
10.1093/INFDIS/JIS552
P407
P50
P577
2012-09-10T00:00:00Z